Analyst Gary Nachman works at BMO and is covering the the Healthcare sector with 500 price targets and ratings documented since 2013 spanning on 28 stocks.
Gary Nachman's average stock forecast success ratio is 35.69% with an average time for price targets to be met of 107.07 days.
Most recent stock forecast was given on PHAT, Phathom Pharmaceuticals Inc. at 01-Mar-2023.
Analyst best performing recommendations are on LCI (LANNETT COMPANY, INC).
The best stock recommendation documented was for MNK at 9/5/2019. The price target of $3 was fulfilled within 5 days with a profit of $1.41 (88.68%) receiving and performance score of 177.36.
Average potential price target upside
Currently, out of the existing stock ratings of Gary Nachman - 6 which are a Buy (85.71%), 1 which are a Hold (14.29%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
44
$-2.01 (-4.37%)
32
20 days ago
4/4 (100%)
$0.39 (2.75%)
98
Buy
40
$-6.01 (-13.06%)
47
7 months 12 days ago
6/7 (85.71%)
$4.94 (24.27%)
354
Buy
44
$-2.01 (-4.37%)
33
10 months 8 days ago
4/4 (100%)
$3.84 (17.45%)
355
Hold
2 years 10 months 28 days ago
2/2 (100%)
$6.16 (43.55%)
729
Hold
21
$-25.01 (-54.36%)
21
3 years 26 days ago
6/6 (100%)
$0.56 (3.12%)
80
